economy
February 18, 2026
Inside David Einhorn's eclectic stock portfolio: The value investor shuns AI in favor of a unique mix of companies
Einhorn's latest moves reflect his views on artificial intelligence and the market as a whole.
TL;DR
- David Einhorn's Greenlight Capital invested in Graphic Packaging, Capri Holdings, and healthcare stocks in Q4 2025.
- These investments avoid major tech companies and AI beneficiaries.
- Greenlight increased its stakes in Graphic Packaging and Capri Holdings significantly.
- New investments were also made in healthcare stocks like Acadia Healthcare, Centene, and Henry Schein.
- Einhorn reduced holdings in Teva Pharmaceutical and Roivant Sciences.
- A position was established in software payments stock Global Payments, seen as safe from AI disruption.
- Einhorn is cautious about AI's immediate impact on stock market returns, comparing it to the internet's long-term but not immediate investment payoff.
Continue reading the original article